ENDOCHECK Trademark

Trademark Overview

On Friday, November 17, 2023, a trademark application was filed for ENDOCHECK with the United States Patent and Trademark Office. The USPTO has given the ENDOCHECK trademark a serial number of 98275465. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, November 27, 2024. This trademark is owned by ASPIRA WOMEN'S HEALTH INC.. The ENDOCHECK trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes in the field of endometriosis; medical diagnosis of endometriosis
endocheck

General Information

Serial Number98275465
Word MarkENDOCHECK
Filing DateFriday, November 17, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, November 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes in the field of endometriosis; medical diagnosis of endometriosis

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 29, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameASPIRA WOMEN'S HEALTH INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAUSTIN, TX 78738

Trademark Events

Event DateEvent Description
Tuesday, November 21, 2023NEW APPLICATION ENTERED
Tuesday, April 16, 2024ASSIGNED TO EXAMINER
Wednesday, July 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, July 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, December 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 23, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 23, 2024NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 27, 2024FINAL REFUSAL WRITTEN
Wednesday, November 27, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 27, 2024FINAL REFUSAL E-MAILED

Related Keywords

endocheck medical endometriosis diagnosis field treatment testing diagnostic purposes